{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:39:15Z","timestamp":1793320755486,"version":"4.5.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T00:00:00Z","timestamp":1518998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K01014X\/1"],"award-info":[{"award-number":["MR\/K01014X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R000743\/1"],"award-info":[{"award-number":["MR\/R000743\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s12035-018-0947-6","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T05:37:05Z","timestamp":1519018625000},"page":"7789-7801","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":136,"title":["Towards a TDP-43-Based Biomarker for ALS and FTLD"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5905-3826","authenticated-orcid":false,"given":"Emily","family":"Feneberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Ansorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,19]]},"reference":[{"issue":"6","key":"947_CR1","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1128\/JVI.69.6.3584-3596.1995","volume":"69","author":"SH Ou","year":"1995","unstructured":"Ou SH, Wu F, Harrich D, Garcia-Martinez LF, Gaynor RB (1995) Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol 69(6):3584\u20133596","journal-title":"J Virol"},{"issue":"10","key":"947_CR2","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1111\/j.1742-4658.2010.07643.x","volume":"277","author":"E Buratti","year":"2010","unstructured":"Buratti E, De Conti L, Stuani C, Romano M, Baralle M, Baralle F (2010) Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J 277(10):2268\u20132281. https:\/\/doi.org\/10.1111\/j.1742-4658.2010.07643.x","journal-title":"FEBS J"},{"issue":"9769","key":"947_CR3","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC (2011) Amyotrophic lateral sclerosis. Lancet (London, England) 377(9769):942\u2013955. https:\/\/doi.org\/10.1016\/S0140-6736(10)61156-7","journal-title":"Lancet (London, England)"},{"issue":"10047","key":"947_CR4","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/s0140-6736(16)00737-6","volume":"388","author":"JR Burrell","year":"2016","unstructured":"Burrell JR, Halliday GM, Kril JJ, Ittner LM, Gotz J, Kiernan MC, Hodges JR (2016) The frontotemporal dementia-motor neuron disease continuum. Lancet (London, England) 388(10047):919\u2013931. https:\/\/doi.org\/10.1016\/s0140-6736(16)00737-6","journal-title":"Lancet (London, England)"},{"issue":"7","key":"947_CR5","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1212\/WNL.59.7.1077","volume":"59","author":"C Lomen-Hoerth","year":"2002","unstructured":"Lomen-Hoerth C, Anderson T, Miller B (2002) The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 59(7):1077\u20131079. https:\/\/doi.org\/10.1212\/WNL.59.7.1077","journal-title":"Neurology"},{"issue":"5796","key":"947_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314(5796):130\u2013133. https:\/\/doi.org\/10.1126\/science.1134108","journal-title":"Science"},{"issue":"1","key":"947_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00401-007-0226-5","volume":"114","author":"LK Kwong","year":"2007","unstructured":"Kwong LK, Neumann M, Sampathu DM, Lee VM, Trojanowski JQ (2007) TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease. Acta Neuropathol 114(1):63\u201370. https:\/\/doi.org\/10.1007\/s00401-007-0226-5","journal-title":"Acta Neuropathol"},{"issue":"1","key":"947_CR8","doi-asserted-by":"publisher","first-page":"23281","DOI":"10.1038\/srep23281","volume":"6","author":"F Kametani","year":"2016","unstructured":"Kametani F, Obi T, Shishido T, Akatsu H, Murayama S, Saito Y, Yoshida M, Hasegawa M (2016) Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains. Sci Rep 6(1):23281. https:\/\/doi.org\/10.1038\/srep23281","journal-title":"Sci Rep"},{"issue":"1","key":"947_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ana.21425","volume":"64","author":"M Hasegawa","year":"2008","unstructured":"Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Buratti E et al (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 64(1):60\u201370. https:\/\/doi.org\/10.1002\/ana.21425","journal-title":"Ann Neurol"},{"issue":"1","key":"947_CR10","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1038\/ncomms6845","volume":"6","author":"TJ Cohen","year":"2015","unstructured":"Cohen TJ, Hwang AW, Restrepo CR, Yuan CX, Trojanowski JQ, Lee VM (2015) An acetylation switch controls TDP-43 function and aggregation propensity. Nat Commun 6(1):5845. https:\/\/doi.org\/10.1038\/ncomms6845","journal-title":"Nat Commun"},{"issue":"13","key":"947_CR11","doi-asserted-by":"publisher","first-page":"8516","DOI":"10.1074\/jbc.M809462200","volume":"284","author":"LM Igaz","year":"2009","unstructured":"Igaz LM, Kwong LK, Chen-Plotkin A, Winton MJ, Unger TL, Xu Y, Neumann M, Trojanowski JQ et al (2009) Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies. J Biol Chem 284(13):8516\u20138524. https:\/\/doi.org\/10.1074\/jbc.M809462200","journal-title":"J Biol Chem"},{"issue":"2","key":"947_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.febslet.2008.12.031","volume":"583","author":"T Nonaka","year":"2009","unstructured":"Nonaka T, Arai T, Buratti E, Baralle FE, Akiyama H, Hasegawa M (2009) Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells. FEBS Lett 583(2):394\u2013400. https:\/\/doi.org\/10.1016\/j.febslet.2008.12.031","journal-title":"FEBS Lett"},{"issue":"10","key":"947_CR13","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S1474-4422(10)70195-2","volume":"9","author":"IR Mackenzie","year":"2010","unstructured":"Mackenzie IR, Rademakers R, Neumann M (2010) TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol 9(10):995\u20131007. https:\/\/doi.org\/10.1016\/S1474-4422(10)70195-2","journal-title":"Lancet Neurol"},{"issue":"34","key":"947_CR14","doi-asserted-by":"publisher","first-page":"26304","DOI":"10.1074\/jbc.M110.125039","volume":"285","author":"RA Fuentealba","year":"2010","unstructured":"Fuentealba RA, Udan M, Bell S, Wegorzewska I, Shao J, Diamond MI, Weihl CC, Baloh RH (2010) Interaction with polyglutamine aggregates reveals a Q\/N-rich domain in TDP-43. J Biol Chem 285(34):26304\u201326314. https:\/\/doi.org\/10.1074\/jbc.M110.125039","journal-title":"J Biol Chem"},{"issue":"45","key":"947_CR15","doi-asserted-by":"publisher","first-page":"37572","DOI":"10.1074\/jbc.M505557200","volume":"280","author":"E Buratti","year":"2005","unstructured":"Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, Baralle FE (2005) TDP-43 binds heterogeneous nuclear ribonucleoprotein a\/B through its C-terminal tail: An important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem 280(45):37572\u201337584. https:\/\/doi.org\/10.1074\/jbc.M505557200","journal-title":"J Biol Chem"},{"issue":"2","key":"947_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/emboj.2010.310","volume":"30","author":"YM Ayala","year":"2011","unstructured":"Ayala YM, De Conti L, Avendano-Vazquez SE, Dhir A, Romano M, D'Ambrogio A, Tollervey J, Ule J et al (2011) TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J 30(2):277\u2013288. https:\/\/doi.org\/10.1038\/emboj.2010.310","journal-title":"EMBO J"},{"issue":"8","key":"947_CR17","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1042\/BCJ20160499","volume":"474","author":"AF Harrison","year":"2017","unstructured":"Harrison AF, Shorter J (2017) RNA-binding proteins with prion-like domains in health and disease. Biochem J 474(8):1417\u20131438. https:\/\/doi.org\/10.1042\/BCJ20160499","journal-title":"Biochem J"},{"issue":"1","key":"947_CR18","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1038\/ncomms2303","volume":"3","author":"T Yamashita","year":"2012","unstructured":"Yamashita T, Hideyama T, Hachiga K, Teramoto S, Takano J, Iwata N, Saido TC, Kwak S (2012) A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology. Nat Commun 3(1):1307. https:\/\/doi.org\/10.1038\/ncomms2303","journal-title":"Nat Commun"},{"issue":"1","key":"947_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0888-7543(03)00214-3","volume":"83","author":"HY Wang","year":"2004","unstructured":"Wang HY, Wang IF, Bose J, Shen CK (2004) Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics 83(1):130\u2013139. https:\/\/doi.org\/10.1016\/S0888-7543(03)00214-3","journal-title":"Genomics"},{"issue":"19","key":"947_CR20","doi-asserted-by":"publisher","first-page":"13302","DOI":"10.1074\/jbc.M800342200","volume":"283","author":"MJ Winton","year":"2008","unstructured":"Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, Lee VM (2008) Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J Biol Chem 283(19):13302\u201313309. https:\/\/doi.org\/10.1074\/jbc.M800342200","journal-title":"J Biol Chem"},{"issue":"Pt 6","key":"947_CR21","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/brain\/awq111","volume":"133","author":"AL Nishimura","year":"2010","unstructured":"Nishimura AL, Zupunski V, Troakes C, Kathe C, Fratta P, Howell M, Gallo JM, Hortobagyi T et al (2010) Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration. Brain 133(Pt 6):1763\u20131771. https:\/\/doi.org\/10.1093\/brain\/awq111","journal-title":"Brain"},{"key":"947_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.abb.2014.01.007","volume":"545","author":"M Mompean","year":"2014","unstructured":"Mompean M, Buratti E, Guarnaccia C, Brito RM, Chakrabartty A, Baralle FE, Laurents DV (2014) Structural characterization of the minimal segment of TDP-43 competent for aggregation. Arch Biochem Biophys 545:53\u201362. https:\/\/doi.org\/10.1016\/j.abb.2014.01.007","journal-title":"Arch Biochem Biophys"},{"issue":"30","key":"947_CR23","doi-asserted-by":"publisher","first-page":"20329","DOI":"10.1074\/jbc.M109.010264","volume":"284","author":"BS Johnson","year":"2009","unstructured":"Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, Gitler AD (2009) TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J Biol Chem 284(30):20329\u201320339. https:\/\/doi.org\/10.1074\/jbc.M109.010264","journal-title":"J Biol Chem"},{"issue":"4","key":"947_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/ana.21344","volume":"63","author":"MA Gitcho","year":"2008","unstructured":"Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, Hatanpaa KJ, White CL 3rd et al (2008) TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 63(4):535\u2013538. https:\/\/doi.org\/10.1002\/ana.21344","journal-title":"Ann Neurol"},{"issue":"9","key":"947_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000193","volume":"4","author":"NJ Rutherford","year":"2008","unstructured":"Rutherford NJ, Zhang YJ, Baker M, Gass JM, Finch NA, Xu YF, Stewart H, Kelley BJ et al (2008) Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet 4(9):e1000193. https:\/\/doi.org\/10.1371\/journal.pgen.1000193","journal-title":"PLoS Genet"},{"issue":"3","key":"947_CR26","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/jnnp.2008.157677","volume":"80","author":"R Lemmens","year":"2009","unstructured":"Lemmens R, Race V, Hersmus N, Matthijs G, Van Den Bosch L, Van Damme P, Dubois B, Boonen S et al (2009) TDP-43 M311V mutation in familial amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 80(3):354\u2013355. https:\/\/doi.org\/10.1136\/jnnp.2008.157677","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"947_CR27","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1001\/archneur.65.9.1185","volume":"65","author":"P Kuhnlein","year":"2008","unstructured":"Kuhnlein P, Sperfeld AD, Vanmassenhove B, Van Deerlin V, Lee VM, Trojanowski JQ, Kretzschmar HA, Ludolph AC et al (2008) Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations. Arch Neurol 65(9):1185\u20131189. https:\/\/doi.org\/10.1001\/archneur.65.9.1185","journal-title":"Arch Neurol"},{"issue":"5870","key":"947_CR28","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1126\/science.1154584","volume":"319","author":"J Sreedharan","year":"2008","unstructured":"Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC et al (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science (New York, NY) 319(5870):1668\u20131672. https:\/\/doi.org\/10.1126\/science.1154584","journal-title":"Science (New York, NY)"},{"issue":"2","key":"947_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/jmg.2008.062463","volume":"46","author":"H Daoud","year":"2009","unstructured":"Daoud H, Valdmanis PN, Kabashi E, Dion P, Dupre N, Camu W, Meininger V, Rouleau GA (2009) Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis. J Med Genet 46(2):112\u2013114. https:\/\/doi.org\/10.1136\/jmg.2008.062463","journal-title":"J Med Genet"},{"issue":"6","key":"947_CR30","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/j.1468-1331.2009.02574.x","volume":"16","author":"R Bo Del","year":"2009","unstructured":"Del Bo R, Ghezzi S, Corti S, Pandolfo M, Ranieri M, Santoro D, Ghione I, Prelle A et al (2009) TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: Identification of two novel mutations. Eur J Neurol 16(6):727\u2013732. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02574.x","journal-title":"Eur J Neurol"},{"issue":"1","key":"947_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1212\/WNL.0b013e31825dceca","volume":"79","author":"S Lattante","year":"2012","unstructured":"Lattante S, Conte A, Zollino M, Luigetti M, Del Grande A, Marangi G, Romano A, Marcaccio A et al (2012) Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease. Neurology 79(1):66\u201372. https:\/\/doi.org\/10.1212\/WNL.0b013e31825dceca","journal-title":"Neurology"},{"issue":"4","key":"947_CR32","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/ana.21612","volume":"65","author":"L Benajiba","year":"2009","unstructured":"Benajiba L, Le Ber I, Camuzat A, Lacoste M, Thomas-Anterion C, Couratier P, Legallic S, Salachas F et al (2009) TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol 65(4):470\u2013473. https:\/\/doi.org\/10.1002\/ana.21612","journal-title":"Ann Neurol"},{"issue":"11","key":"947_CR33","doi-asserted-by":"publisher","first-page":"E974","DOI":"10.1002\/humu.21100","volume":"30","author":"B Borroni","year":"2009","unstructured":"Borroni B, Bonvicini C, Alberici A, Buratti E, Agosti C, Archetti S, Papetti A, Stuani C et al (2009) Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Hum Mutat 30(11):E974\u2013E983. https:\/\/doi.org\/10.1002\/humu.21100","journal-title":"Hum Mutat"},{"issue":"12","key":"947_CR34","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/mds.22697","volume":"24","author":"GG Kovacs","year":"2009","unstructured":"Kovacs GG, Murrell JR, Horvath S, Haraszti L, Majtenyi K, Molnar MJ, Budka H, Ghetti B et al (2009) TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov Disord 24(12):1843\u20131847. https:\/\/doi.org\/10.1002\/mds.22697","journal-title":"Mov Disord"},{"issue":"5","key":"947_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S1474-4422(08)70071-1","volume":"7","author":"VM Deerlin Van","year":"2008","unstructured":"Van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, Elman LB, Clay D, Wood EM et al (2008) TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: A genetic and histopathological analysis. Lancet Neurol 7(5):409\u2013416. https:\/\/doi.org\/10.1016\/S1474-4422(08)70071-1","journal-title":"Lancet Neurol"},{"issue":"5","key":"947_CR36","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/ng.132","volume":"40","author":"E Kabashi","year":"2008","unstructured":"Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, Bouchard JP, Lacomblez L et al (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40(5):572\u2013574. https:\/\/doi.org\/10.1038\/ng.132","journal-title":"Nat Genet"},{"issue":"1","key":"947_CR37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3121","volume":"13","author":"EB Lee","year":"2011","unstructured":"Lee EB, Lee VM, Trojanowski JQ (2011) Gains or losses: Molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci 13(1):38\u201350. https:\/\/doi.org\/10.1038\/nrn3121","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"947_CR38","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"SC Ling","year":"2013","unstructured":"Ling SC, Polymenidou M, Cleveland DW (2013) Converging mechanisms in ALS and FTD: Disrupted RNA and protein homeostasis. Neuron 79(3):416\u2013438. https:\/\/doi.org\/10.1016\/j.neuron.2013.07.033","journal-title":"Neuron"},{"issue":"4","key":"947_CR39","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/hmg\/ddp534","volume":"19","author":"E Kabashi","year":"2010","unstructured":"Kabashi E, Lin L, Tradewell ML, Dion PA, Bercier V, Bourgouin P, Rochefort D, Bel Hadj S et al (2010) Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum Mol Genet 19(4):671\u2013683. https:\/\/doi.org\/10.1093\/hmg\/ddp534","journal-title":"Hum Mol Genet"},{"issue":"18","key":"947_CR40","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1093\/hmg\/ddp275","volume":"18","author":"T Nonaka","year":"2009","unstructured":"Nonaka T, Kametani F, Arai T, Akiyama H, Hasegawa M (2009) Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum Mol Genet 18(18):3353\u20133364. https:\/\/doi.org\/10.1093\/hmg\/ddp275","journal-title":"Hum Mol Genet"},{"issue":"2","key":"947_CR41","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1523\/JNEUROSCI.4988-09.2010","volume":"30","author":"SJ Barmada","year":"2010","unstructured":"Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S (2010) Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci 30(2):639\u2013649. https:\/\/doi.org\/10.1523\/JNEUROSCI.4988-09.2010","journal-title":"J Neurosci"},{"issue":"44","key":"947_CR42","doi-asserted-by":"publisher","first-page":"18809","DOI":"10.1073\/pnas.0908767106","volume":"106","author":"I Wegorzewska","year":"2009","unstructured":"Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH (2009) TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A 106(44):18809\u201318814. https:\/\/doi.org\/10.1073\/pnas.0908767106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"947_CR43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12035-013-8427-5","volume":"48","author":"J Janssens","year":"2013","unstructured":"Janssens J, Wils H, Kleinberger G, Joris G, Cuijt I, Ceuterick-de Groote C, Van Broeckhoven C, Kumar-Singh S (2013) Overexpression of ALS-associated p.M337V human TDP-43 in mice worsens disease features compared to wild-type human TDP-43 mice. Mol Neurobiol 48(1):22\u201335. https:\/\/doi.org\/10.1007\/s12035-013-8427-5","journal-title":"Mol Neurobiol"},{"issue":"21","key":"947_CR44","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.15252\/embj.201694221","volume":"35","author":"BM Schwenk","year":"2016","unstructured":"Schwenk BM, Hartmann H, Serdaroglu A, Schludi MH, Hornburg D, Meissner F, Orozco D, Colombo A et al (2016) TDP-43 loss of function inhibits endosomal trafficking and alters trophic signaling in neurons. EMBO J 35(21):2350\u20132370. https:\/\/doi.org\/10.15252\/embj.201694221","journal-title":"EMBO J"},{"key":"947_CR45","doi-asserted-by":"publisher","first-page":"4824","DOI":"10.1038\/ncomms5824","volume":"5","author":"YS Fang","year":"2014","unstructured":"Fang YS, Tsai KJ, Chang YJ, Kao P, Woods R, Kuo PH, Wu CC, Liao JY et al (2014) Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients. Nat Commun 5:4824. https:\/\/doi.org\/10.1038\/ncomms5824","journal-title":"Nat Commun"},{"key":"947_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neures.2015.12.006","volume":"107","author":"T Yamashita","year":"2016","unstructured":"Yamashita T, Teramoto S, Kwak S (2016) Phosphorylated TDP-43 becomes resistant to cleavage by calpain: a regulatory role for phosphorylation in TDP-43 pathology of ALS\/FTLD. Neurosci Res 107:63\u201369. https:\/\/doi.org\/10.1016\/j.neures.2015.12.006","journal-title":"Neurosci Res"},{"issue":"3","key":"947_CR47","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351(3):602\u2013611. https:\/\/doi.org\/10.1016\/j.bbrc.2006.10.093","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"947_CR48","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.bbrc.2009.03.038","volume":"382","author":"F Kametani","year":"2009","unstructured":"Kametani F, Nonaka T, Suzuki T, Arai T, Dohmae N, Akiyama H, Hasegawa M (2009) Identification of casein kinase-1 phosphorylation sites on TDP-43. Biochem Biophys Res Commun 382(2):405\u2013409. https:\/\/doi.org\/10.1016\/j.bbrc.2009.03.038","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"947_CR49","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-008-0477-9","volume":"117","author":"M Neumann","year":"2009","unstructured":"Neumann M, Kwong LK, Lee EB, Kremmer E, Flatley A, Xu Y, Forman MS, Troost D et al (2009) Phosphorylation of S409\/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol 117(2):137\u2013149. https:\/\/doi.org\/10.1007\/s00401-008-0477-9","journal-title":"Acta Neuropathol"},{"issue":"11","key":"947_CR50","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1074\/jbc.M115.695379","volume":"291","author":"T Nonaka","year":"2016","unstructured":"Nonaka T, Suzuki G, Tanaka Y, Kametani F, Hirai S, Okado H, Miyashita T, Saitoe M et al (2016) Phosphorylation of TAR DNA-binding protein of 43\u00a0kDa (TDP-43) by truncated casein kinase 1delta triggers mislocalization and accumulation of TDP-43. J Biol Chem 291(11):5473\u20135483. https:\/\/doi.org\/10.1074\/jbc.M115.695379","journal-title":"J Biol Chem"},{"issue":"2","key":"947_CR51","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1471-4159.2010.07098.x","volume":"116","author":"OA Brady","year":"2011","unstructured":"Brady OA, Meng P, Zheng Y, Mao Y, Hu F (2011) Regulation of TDP-43 aggregation by phosphorylation and p62\/SQSTM1. J Neurochem 116(2):248\u2013259. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.07098.x","journal-title":"J Neurochem"},{"issue":"1","key":"947_CR52","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ana.23937","volume":"74","author":"J Brettschneider","year":"2013","unstructured":"Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M, Suh E, Van Deerlin VM et al (2013) Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 74(1):20\u201338. https:\/\/doi.org\/10.1002\/ana.23937","journal-title":"Ann Neurol"},{"issue":"3","key":"947_CR53","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00401-013-1238-y","volume":"127","author":"J Brettschneider","year":"2014","unstructured":"Brettschneider J, Del Tredici K, Irwin DJ, Grossman M, Robinson JL, Toledo JB, Lee EB, Fang L et al (2014) Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD). Acta Neuropathol 127(3):423\u2013439. https:\/\/doi.org\/10.1007\/s00401-013-1238-y","journal-title":"Acta Neuropathol"},{"issue":"1","key":"947_CR54","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","volume":"122","author":"IR Mackenzie","year":"2011","unstructured":"Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, Perry RH, Trojanowski JQ et al (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122(1):111\u2013113. https:\/\/doi.org\/10.1007\/s00401-011-0845-8","journal-title":"Acta Neuropathol"},{"issue":"1","key":"947_CR55","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00401-017-1679-9","volume":"134","author":"EB Lee","year":"2017","unstructured":"Lee EB, Porta S, Michael Baer G, Xu Y, Suh E, Kwong LK, Elman L, Grossman M et al (2017) Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol 134(1):65\u201378. https:\/\/doi.org\/10.1007\/s00401-017-1679-9","journal-title":"Acta Neuropathol"},{"issue":"1","key":"947_CR56","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00401-017-1716-8","volume":"134","author":"IR Mackenzie","year":"2017","unstructured":"Mackenzie IR, Neumann M (2017) Reappraisal of TDP-43 pathology in FTLD-U subtypes. Acta Neuropathol 134(1):79\u201396. https:\/\/doi.org\/10.1007\/s00401-017-1716-8","journal-title":"Acta Neuropathol"},{"issue":"1","key":"947_CR57","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2353\/ajpath.2008.080003","volume":"173","author":"LM Igaz","year":"2008","unstructured":"Igaz LM, Kwong LK, Xu Y, Truax AC, Uryu K, Neumann M, Clark CM, Elman LB et al (2008) Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am J Pathol 173(1):182\u2013194. https:\/\/doi.org\/10.2353\/ajpath.2008.080003","journal-title":"Am J Pathol"},{"issue":"1","key":"947_CR58","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00401-016-1633-2","volume":"133","author":"H Braak","year":"2016","unstructured":"Braak H, Ludolph AC, Neumann M, Ravits J, Del Tredici K (2016) Pathological TDP-43 changes in Betz cells differ from those in bulbar and spinal alpha-motoneurons in sporadic amyotrophic lateral sclerosis. Acta Neuropathol 133(1):79\u201390. https:\/\/doi.org\/10.1007\/s00401-016-1633-2","journal-title":"Acta Neuropathol"},{"issue":"4","key":"947_CR59","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1083\/jcb.201504057","volume":"211","author":"MS Feiler","year":"2015","unstructured":"Feiler MS, Strobel B, Freischmidt A, Helferich AM, Kappel J, Brewer BM, Li D, Thal DR et al (2015) TDP-43 is intercellularly transmitted across axon terminals. J Cell Biol 211(4):897\u2013911. https:\/\/doi.org\/10.1083\/jcb.201504057","journal-title":"J Cell Biol"},{"issue":"2","key":"947_CR60","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.neulet.2008.01.060","volume":"434","author":"HX Zhang","year":"2008","unstructured":"Zhang HX, Tanji K, Mori F, Wakabayashi K (2008) Epitope mapping of 2E2-D3, a monoclonal antibody directed against human TDP-43. Neurosci Lett 434(2):170\u2013174. https:\/\/doi.org\/10.1016\/j.neulet.2008.01.060","journal-title":"Neurosci Lett"},{"issue":"1","key":"947_CR61","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/2051-5960-2-33","volume":"2","author":"LK Kwong","year":"2014","unstructured":"Kwong LK, Irwin DJ, Walker AK, Xu Y, Riddle DM, Trojanowski JQ, Lee VM (2014) Novel monoclonal antibodies to normal and pathologically altered human TDP-43 proteins. Acta Neuropathol Commun 2(1):33. https:\/\/doi.org\/10.1186\/2051-5960-2-33","journal-title":"Acta Neuropathol Commun"},{"issue":"7","key":"947_CR62","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B, Lautner R, Andreasson U, Ohrfelt A, Portelius E, Bjerke M, Holtta M, Rosen C et al (2016) CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol 15(7):673\u2013684. https:\/\/doi.org\/10.1016\/S1474-4422(16)00070-3","journal-title":"Lancet Neurol"},{"key":"947_CR63","first-page":"39","volume":"61","author":"DJ Begley","year":"2003","unstructured":"Begley DJ, Brightman MW (2003) Structural and functional aspects of the blood-brain barrier. Prog Drug Res 61:39\u201378","journal-title":"Prog Drug Res"},{"key":"947_CR64","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-1-60761-938-3_4","volume":"686","author":"CE Johanson","year":"2011","unstructured":"Johanson CE, Stopa EG, McMillan PN (2011) The blood-cerebrospinal fluid barrier: structure and functional significance. Methods Mol Biol 686:101\u2013131. https:\/\/doi.org\/10.1007\/978-1-60761-938-3_4","journal-title":"Methods Mol Biol"},{"issue":"24","key":"947_CR65","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/BF01466734","volume":"52","author":"K Felgenhauer","year":"1974","unstructured":"Felgenhauer K (1974) Protein size and cerebrospinal fluid composition. Klin Wochenschr 52(24):1158\u20131164. https:\/\/doi.org\/10.1007\/BF01466734","journal-title":"Klin Wochenschr"},{"issue":"11","key":"947_CR66","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1001\/archneur.65.11.1481","volume":"65","author":"P Steinacker","year":"2008","unstructured":"Steinacker P, Hendrich C, Sperfeld AD, Jesse S, von Arnim CA, Lehnert S, Pabst A, Uttner I et al (2008) TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol 65(11):1481\u20131487. https:\/\/doi.org\/10.1001\/archneur.65.11.1481","journal-title":"Arch Neurol"},{"issue":"1","key":"947_CR67","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41467-017-00062-0","volume":"8","author":"T Afroz","year":"2017","unstructured":"Afroz T, Hock EM, Ernst P, Foglieni C, Jambeau M, Gilhespy LAB, Laferriere F, Maniecka Z et al (2017) Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nat Commun 8(1):45. https:\/\/doi.org\/10.1038\/s41467-017-00062-0","journal-title":"Nat Commun"},{"issue":"5","key":"947_CR68","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00401-010-0786-7","volume":"121","author":"G Marco De","year":"2011","unstructured":"De Marco G, Lupino E, Calvo A, Moglia C, Buccinna B, Grifoni S, Ramondetti C, Lomartire A et al (2011) Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations. Acta Neuropathol 121(5):611\u2013622. https:\/\/doi.org\/10.1007\/s00401-010-0786-7","journal-title":"Acta Neuropathol"},{"issue":"5\u20136","key":"947_CR69","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3109\/21678421.2014.905606","volume":"15","author":"E Feneberg","year":"2014","unstructured":"Feneberg E, Steinacker P, Lehnert S, Schneider A, Walther P, Thal DR, Linsenmeier M, Ludolph AC et al (2014) Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases. Amyotrophic lateral sclerosis & frontotemporal degeneration 15(5\u20136):351\u2013356. https:\/\/doi.org\/10.3109\/21678421.2014.905606","journal-title":"Amyotrophic lateral sclerosis & frontotemporal degeneration"},{"issue":"6","key":"947_CR70","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrneurol.2016.68","volume":"12","author":"AG Thompson","year":"2016","unstructured":"Thompson AG, Gray E, Heman-Ackah SM, Mager I, Talbot K, Andaloussi SE, Wood MJ, Turner MR (2016) Extracellular vesicles in neurodegenerative disease\u2014pathogenesis to biomarkers. Nat Rev Neurol 12(6):346\u2013357. https:\/\/doi.org\/10.1038\/nrneurol.2016.68","journal-title":"Nat Rev Neurol"},{"issue":"Pt 12","key":"947_CR71","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1093\/brain\/aww237","volume":"139","author":"Y Iguchi","year":"2016","unstructured":"Iguchi Y, Eid L, Parent M, Soucy G, Bareil C, Riku Y, Kawai K, Takagi S et al (2016) Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain 139(Pt 12):3187\u20133201. https:\/\/doi.org\/10.1093\/brain\/aww237","journal-title":"Brain"},{"issue":"1","key":"947_CR72","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00401-008-0456-1","volume":"117","author":"T Kasai","year":"2009","unstructured":"Kasai T, Tokuda T, Ishigami N, Sasayama H, Foulds P, Mitchell DJ, Mann DM, Allsop D et al (2009) Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neuropathol 117(1):55\u201362. https:\/\/doi.org\/10.1007\/s00401-008-0456-1","journal-title":"Acta Neuropathol"},{"issue":"2","key":"947_CR73","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/17482968.2010.541263","volume":"12","author":"Y Noto","year":"2011","unstructured":"Noto Y, Shibuya K, Sato Y, Kanai K, Misawa S, Sawai S, Mori M, Uchiyama T et al (2011) Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value. Amyotroph Lateral Scler 12(2):140\u2013143. https:\/\/doi.org\/10.3109\/17482968.2010.541263","journal-title":"Amyotroph Lateral Scler"},{"issue":"1","key":"947_CR74","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000444788","volume":"6","author":"A Junttila","year":"2016","unstructured":"Junttila A, Kuvaja M, Hartikainen P, Siloaho M, Helisalmi S, Moilanen V, Kiviharju A, Jansson L et al (2016) Cerebrospinal fluid TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis patients with and without the C9ORF72 hexanucleotide expansion. Dement Geriatr Cogn Dis Extra 6(1):142\u2013149. https:\/\/doi.org\/10.1159\/000444788","journal-title":"Dement Geriatr Cogn Dis Extra"},{"issue":"2","key":"947_CR75","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3233\/JAD-160386","volume":"55","author":"HB Kuiperij","year":"2017","unstructured":"Kuiperij HB, Versleijen AA, Beenes M, Verwey NA, Benussi L, Paterlini A, Binetti G, Teunissen CE et al (2017) Tau rather than TDP-43 proteins are potential cerebrospinal fluid biomarkers for frontotemporal lobar degeneration subtypes: a pilot study. J Alzheimers Dis 55(2):585\u2013595. https:\/\/doi.org\/10.3233\/JAD-160386","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"947_CR76","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00401-008-0389-8","volume":"116","author":"P Foulds","year":"2008","unstructured":"Foulds P, McAuley E, Gibbons L, Davidson Y, Pickering-Brown SM, Neary D, Snowden JS, Allsop D et al (2008) TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer\u2019s disease and frontotemporal lobar degeneration. Acta Neuropathol 116(2):141\u2013146. https:\/\/doi.org\/10.1007\/s00401-008-0389-8","journal-title":"Acta Neuropathol"},{"issue":"5","key":"947_CR77","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00401-009-0594-0","volume":"118","author":"PG Foulds","year":"2009","unstructured":"Foulds PG, Davidson Y, Mishra M, Hobson DJ, Humphreys KM, Taylor M, Johnson N, Weintraub S et al (2009) Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration. Acta Neuropathol 118(5):647\u2013658. https:\/\/doi.org\/10.1007\/s00401-009-0594-0","journal-title":"Acta Neuropathol"},{"issue":"5","key":"947_CR78","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3109\/17482968.2012.703208","volume":"13","author":"E Verstraete","year":"2012","unstructured":"Verstraete E, Kuiperij HB, van Blitterswijk MM, Veldink JH, Schelhaas HJ, van den Berg LH, Verbeek MM (2012) TDP-43 plasma levels are higher in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 13(5):446\u2013451. https:\/\/doi.org\/10.3109\/17482968.2012.703208","journal-title":"Amyotroph Lateral Scler"},{"issue":"6","key":"947_CR79","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1136\/jnnp-2013-305972","volume":"85","author":"M Suarez-Calvet","year":"2014","unstructured":"Suarez-Calvet M, Dols-Icardo O, Llado A, Sanchez-Valle R, Hernandez I, Amer G, Anton-Aguirre S, Alcolea D et al (2014) Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation. J Neurol Neurosurg Psychiatry 85(6):684\u2013691. https:\/\/doi.org\/10.1136\/jnnp-2013-305972","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"947_CR80","doi-asserted-by":"publisher","first-page":"6157","DOI":"10.1073\/pnas.95.11.6157","volume":"95","author":"MD Sheets","year":"1998","unstructured":"Sheets MD, Amersdorfer P, Finnern R, Sargent P, Lindquist E, Schier R, Hemingsen G, Wong C et al (1998) Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. Proc Natl Acad Sci U S A 95(11):6157\u20136162. https:\/\/doi.org\/10.1073\/pnas.95.11.6157","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"947_CR81","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12868-017-0334-7","volume":"18","author":"SM Williams","year":"2017","unstructured":"Williams SM, Khan G, Harris BT, Ravits J, Sierks MR (2017) TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis. BMC Neurosci 18(1):20. https:\/\/doi.org\/10.1186\/s12868-017-0334-7","journal-title":"BMC Neurosci"},{"issue":"1","key":"947_CR82","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40478-015-0195-1","volume":"3","author":"J Goossens","year":"2015","unstructured":"Goossens J, Vanmechelen E, Trojanowski JQ, Lee VM, Van Broeckhoven C, van der Zee J, Engelborghs S (2015) TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies. Acta Neuropathol Commun 3(1):15. https:\/\/doi.org\/10.1186\/s40478-015-0195-1","journal-title":"Acta Neuropathol Commun"},{"issue":"10","key":"947_CR83","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1212\/WNL.0b013e3181b6bbbd","volume":"73","author":"JM Ravits","year":"2009","unstructured":"Ravits JM, La Spada AR (2009) ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 73(10):805\u2013811. https:\/\/doi.org\/10.1212\/WNL.0b013e3181b6bbbd","journal-title":"Neurology"},{"issue":"7","key":"947_CR84","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1021\/acs.analchem.5b04509","volume":"88","author":"W Mair","year":"2016","unstructured":"Mair W, Muntel J, Tepper K, Tang S, Biernat J, Seeley WW, Kosik KS, Mandelkow E et al (2016) FLEXITau: quantifying post-translational modifications of tau protein in vitro and in human disease. Anal Chem 88(7):3704\u20133714. https:\/\/doi.org\/10.1021\/acs.analchem.5b04509","journal-title":"Anal Chem"},{"issue":"11","key":"947_CR85","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1021\/acs.jproteome.5b00804","volume":"14","author":"MA Collins","year":"2015","unstructured":"Collins MA, An J, Hood BL, Conrads TP, Bowser RP (2015) Label-free LC-MS\/MS proteomic analysis of cerebrospinal fluid identifies protein\/pathway alterations and candidate biomarkers for amyotrophic lateral sclerosis. J Proteome Res 14(11):4486\u20134501. https:\/\/doi.org\/10.1021\/acs.jproteome.5b00804","journal-title":"J Proteome Res"},{"issue":"4","key":"947_CR86","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.neuron.2017.07.025","volume":"95","author":"IR Mackenzie","year":"2017","unstructured":"Mackenzie IR, Nicholson AM, Sarkar M, Messing J, Purice MD, Pottier C, Annu K, Baker M et al (2017) TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and Alter stress granule dynamics. Neuron 95(4):808\u2013816 e809. https:\/\/doi.org\/10.1016\/j.neuron.2017.07.025","journal-title":"Neuron"},{"issue":"10","key":"947_CR87","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","volume":"54","author":"J Kuhle","year":"2016","unstructured":"Kuhle J, Barro C, Andreasson U, Derfuss T, Lindberg R, Sandelius A, Liman V, Norgren N et al (2016) Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Clin Chem Lab Med 54(10):1655\u20131661. https:\/\/doi.org\/10.1515\/cclm-2015-1195","journal-title":"Clin Chem Lab Med"},{"issue":"12","key":"947_CR88","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1177\/1352458515623365","volume":"22","author":"J Kuhle","year":"2016","unstructured":"Kuhle J, Barro C, Disanto G, Mathias A, Soneson C, Bonnier G, Yaldizli O, Regeniter A et al (2016) Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity. Mult Scler 22(12):1550\u20131559. https:\/\/doi.org\/10.1177\/1352458515623365","journal-title":"Mult Scler"},{"issue":"1","key":"947_CR89","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-017-0206-8","volume":"12","author":"H Tatebe","year":"2017","unstructured":"Tatebe H, Kasai T, Ohmichi T, Kishi Y, Kakeya T, Waragai M, Kondo M, Allsop D et al (2017) Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer\u2019s disease and down syndrome. Mol Neurodegener 12(1):63. https:\/\/doi.org\/10.1186\/s13024-017-0206-8","journal-title":"Mol Neurodegener"},{"issue":"8","key":"947_CR90","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/1439-7633(20020802)3:8<717::AID-CBIC717>3.0.CO;2-C","volume":"3","author":"D Proske","year":"2002","unstructured":"Proske D, Gilch S, Wopfner F, Schatzl HM, Winnacker EL, Famulok M (2002) Prion-protein-specific aptamer reduces PrPSc formation. Chembiochem 3(8):717\u2013725. https:\/\/doi.org\/10.1002\/1439-7633(20020802)3:8<717::AID-CBIC717>3.0.CO;2-C","journal-title":"Chembiochem"},{"issue":"2","key":"947_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089901","volume":"9","author":"CT Farrar","year":"2014","unstructured":"Farrar CT, William CM, Hudry E, Hashimoto T, Hyman BT (2014) RNA aptamer probes as optical imaging agents for the detection of amyloid plaques. PLoS One 9(2):e89901. https:\/\/doi.org\/10.1371\/journal.pone.0089901","journal-title":"PLoS One"},{"issue":"13","key":"947_CR92","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1021\/ac300330g","volume":"84","author":"K Tsukakoshi","year":"2012","unstructured":"Tsukakoshi K, Abe K, Sode K, Ikebukuro K (2012) Selection of DNA aptamers that recognize alpha-synuclein oligomers using a competitive screening method. Anal Chem 84(13):5542\u20135547. https:\/\/doi.org\/10.1021\/ac300330g","journal-title":"Anal Chem"},{"issue":"13","key":"947_CR93","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1021\/acs.jpclett.5b00918","volume":"6","author":"M Mompean","year":"2015","unstructured":"Mompean M, Hervas R, Xu Y, Tran TH, Guarnaccia C, Buratti E, Baralle F, Tong L et al (2015) Structural evidence of amyloid fibril formation in the putative aggregation domain of TDP-43. J Phys Chem Lett 6(13):2608\u20132615. https:\/\/doi.org\/10.1021\/acs.jpclett.5b00918","journal-title":"J Phys Chem Lett"},{"issue":"15","key":"947_CR94","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1093\/hmg\/ddt166","volume":"22","author":"YJ Zhang","year":"2013","unstructured":"Zhang YJ, Caulfield T, Xu YF, Gendron TF, Hubbard J, Stetler C, Sasaguri H, Whitelaw EC et al (2013) The dual functions of the extreme N-terminus of TDP-43 in regulating its biological activity and inclusion formation. Hum Mol Genet 22(15):3112\u20133122. https:\/\/doi.org\/10.1093\/hmg\/ddt166","journal-title":"Hum Mol Genet"},{"issue":"2","key":"947_CR95","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1021\/pr901076y","volume":"9","author":"BD Freibaum","year":"2010","unstructured":"Freibaum BD, Chitta RK, High AA, Taylor JP (2010) Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res 9(2):1104\u20131120. https:\/\/doi.org\/10.1021\/pr901076y","journal-title":"J Proteome Res"},{"issue":"2","key":"947_CR96","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00401-016-1575-8","volume":"132","author":"AM Blokhuis","year":"2016","unstructured":"Blokhuis AM, Koppers M, Groen EJ, van den Heuvel DM, Dini Modigliani S, Anink JJ, Fumoto K, van Diggelen F et al (2016) Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways. Acta Neuropathol 132(2):175\u2013196. https:\/\/doi.org\/10.1007\/s00401-016-1575-8","journal-title":"Acta Neuropathol"},{"issue":"11","key":"947_CR97","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1038\/nprot.2014.164","volume":"9","author":"JH Morris","year":"2014","unstructured":"Morris JH, Knudsen GM, Verschueren E, Johnson JR, Cimermancic P, Greninger AL, Pico AR (2014) Affinity purification-mass spectrometry and network analysis to understand protein-protein interactions. Nat Protoc 9(11):2539\u20132554. https:\/\/doi.org\/10.1038\/nprot.2014.164","journal-title":"Nat Protoc"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-0947-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-0947-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-0947-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T08:19:46Z","timestamp":1603873186000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-0947-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,19]]},"references-count":97,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["947"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-0947-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,19]]},"assertion":[{"value":"2 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}